{
  "id": 4844051,
  "title": "NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier",
  "url": "https://urgent.news/2026/09/01/netramark-strengthens-board-of-directors-with-appointment-of-veteran",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-01T11:05:35.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/netramark-strengthens-board-of-directors-with-appointment-of-veteran-pharmaceutical-executive-dr-keith-fournier"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pharmaceutical industry leader brings more than 20 years of global drug development, regulatory strategy and portfolio leadership experience across AbbVie, Merck KGaA, AstraZeneca and Abivax TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a clinical intelligence company transforming clinical trials with…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}